Osteoporosis is one of the most common chronic diseases worldwide, with global cases set to surge in coming decades. To effectively manage this condition, combined calcium and vitamin D supplementation is often recommended long-term. But such supplements in traditional tablet form tend to be bulky, chalky tasting and can lead to significant swallowing difficulties, highlighting the need for more convenient, user-friendly alternatives.
In this article, published in both Nutraceutical Business Review and Manufacturing Chemist, HERMES PHARMA’s Dr. Martin Koeberle (Head of Analytical Development & Stability Testing) and Dr. Verena Garsuch (Manager Analytical and Clinical Development & Stability Testing) discuss:
- The critical need for great-tasting, user-friendly combined calcium and vitamin D supplements to boost compliance in those with osteoporosis
- How large volumes of calcium and small doses of extremely sensitive vitamin D pose significant formulation and manufacturing challenges for such supplements
- The expertise and technologies available to overcome these formulation hurdles, making a variety of high-quality user-friendly dosage forms available to the market